(Q26992146)

R. Khanna

series ordinal

2

1 reference

language of work or name

1 reference

February 2013

1 reference

American Journal of Transplantation

published in

1 reference

volume

13 Suppl 3

1 reference

page(s)

9-23; quiz 23

1 reference

Viral immune evasion: a masterpiece of evolution

cites work

1 reference

Understanding human T-cell-mediated immunoregulation through herpesviruses

21 January 2018

1 reference

Spectrum of Epstein-Barr virus-associated diseases

21 January 2018

1 reference

Herpesviruses and immunity: the art of evasion

21 January 2018

1 reference

Infections and solid organ transplant rejection: a cause-and-effect relationship?

21 January 2018

1 reference

Recognition of herpesviruses by the innate immune system

21 January 2018

1 reference

Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells

21 January 2018

1 reference

Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.

21 January 2018

1 reference

Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3.

21 January 2018

1 reference

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

Functions of natural killer cells

21 January 2018

1 reference

Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors

21 January 2018

1 reference

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

21 January 2018

1 reference

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

21 January 2018

1 reference

Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

21 January 2018

1 reference

Adaptive immune features of natural killer cells

21 January 2018

1 reference

Implication of gammadelta T cells in the human immune response to cytomegalovirus

21 January 2018

1 reference

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection

21 January 2018

1 reference

Common features of gammadelta T cells and CD8(+) alphabeta T cells responding to human cytomegalovirus infection in kidney transplant recipients

21 January 2018

1 reference

Human cytomegalovirus elicits fetal gammadelta T cell responses in utero

21 January 2018

1 reference

Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.

21 January 2018

1 reference

Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.

21 January 2018

1 reference

Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.

21 January 2018

1 reference

Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection

21 January 2018

1 reference

The cytomegalovirus-specific CD4+ T-cell response expands with age and markedly alters the CD4+ T-cell repertoire.

21 January 2018

1 reference

Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans

21 January 2018

1 reference

Antigen-presenting cells of haematopoietic origin prime cytomegalovirus-specific CD8 T-cells but are not sufficient for driving memory inflation during viral latency.

21 January 2018

1 reference

Non-hematopoietic cells in lymph nodes drive memory CD8 T cell inflation during murine cytomegalovirus infection

21 January 2018

1 reference

Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent

21 January 2018

1 reference

Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors

21 January 2018

1 reference

Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections

21 January 2018

1 reference

IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells.

21 January 2018

1 reference

Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms.

21 January 2018

1 reference

Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells

21 January 2018

1 reference

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults

21 January 2018

1 reference

Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.

21 January 2018

1 reference

Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses

21 January 2018

1 reference

Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

21 January 2018

1 reference

Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure

21 January 2018

1 reference

The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression

21 January 2018

1 reference

Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes.

21 January 2018

1 reference

Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.

21 January 2018

1 reference

CD8+ T-cell recognition of human cytomegalovirus latency-associated determinant pUL138.

21 January 2018

1 reference

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

21 January 2018

1 reference

SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.

21 January 2018

1 reference

Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets

21 January 2018

1 reference

Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.

21 January 2018

1 reference

EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function.

21 January 2018

1 reference

Epstein-Barr virus: new insights

21 January 2018

1 reference

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases

21 January 2018

1 reference

Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression

21 January 2018

1 reference

Discerning regulation of cis- and trans-presentation of CD8+ T-cell epitopes by EBV-encoded oncogene LMP-1 through self-aggregation

21 January 2018

1 reference

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

21 January 2018

1 reference

Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes

21 January 2018

1 reference

Monofunctional and polyfunctional CD8+ T cell responses to human herpesvirus 8 lytic and latency proteins

21 January 2018

1 reference

Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells.

21 January 2018

1 reference

VZV T cell-mediated immunity

21 January 2018

1 reference

Immunology in the Clinic Review Series; focus on host responses: T cell responses to herpes simplex viruses

21 January 2018

1 reference

Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.

21 January 2018

1 reference

Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus

21 January 2018

1 reference

Phenotypic analysis of human CD4+ T cells specific for immediate-early 63 protein of varicella-zoster virus

21 January 2018

1 reference

The presence of lytic HSV-1 transcripts and clonally expanded T cells with a memory effector phenotype in human sensory ganglia

21 January 2018

1 reference

Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia

21 January 2018

1 reference

Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance

21 January 2018

1 reference

Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency

21 January 2018

1 reference

Duration of humoral immunity to common viral and vaccine antigens

21 January 2018

1 reference

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

21 January 2018

1 reference

Age-dependent increase of memory B cell response to cytomegalovirus in healthy adults.

21 January 2018

1 reference

B cell repertoire analysis identifies new antigenic domains on glycoprotein B of human cytomegalovirus which are target of neutralizing antibodies

21 January 2018

1 reference

Glycoprotein H of human cytomegalovirus is a major antigen for the neutralizing humoral immune response

21 January 2018

1 reference

Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex

21 January 2018

1 reference

Vaccine prevention of maternal cytomegalovirus infection

21 January 2018

1 reference

Cytomegalovirus viruria and DNAemia in healthy seropositive women

21 January 2018

1 reference

Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease

21 January 2018

1 reference

Cytomegalovirus reinfections in healthy seroimmune women

21 January 2018

1 reference

Immune response of varicella vaccinees to different varicella-zoster virus genotypes

21 January 2018

1 reference

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

21 January 2018

1 reference

Efficacy results of a trial of a herpes simplex vaccine

21 January 2018

1 reference

Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1.

21 January 2018

1 reference

Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10)

21 January 2018

1 reference

The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity

21 January 2018

1 reference

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40.

21 January 2018

1 reference

The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol

21 January 2018

1 reference

The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP

21 January 2018

1 reference

Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains

21 January 2018

1 reference

The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules

21 January 2018

1 reference

Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1

21 January 2018

1 reference

Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation

21 January 2018

1 reference

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

21 January 2018

1 reference

Immunobiology of human cytomegalovirus: from bench to bedside.

21 January 2018

1 reference

Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy.

21 January 2018

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

21 January 2018

1 reference

Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response

21 January 2018

1 reference

Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.

21 January 2018

1 reference

Polyfunctional cytomegalovirus-specific CD4+ and pp65 CD8+ T cells protect against high-level replication after liver transplantation

21 January 2018

1 reference

Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation

21 January 2018

1 reference

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

21 January 2018

1 reference

Reconstitution of the latent T-lymphocyte response to Epstein-Barr virus is coincident with long-term recovery from posttransplant lymphoma after adoptive immunotherapy

21 January 2018

1 reference

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients

21 January 2018

1 reference

Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.

21 January 2018

1 reference

Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation

21 January 2018

1 reference

Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.

21 January 2018

1 reference

Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity

21 January 2018

1 reference

Findings and conclusions from CMV hyperimmune globulin treatment trials

21 January 2018

1 reference

Successful immunotherapy of HCMV disease using virus-specific T cells expanded from an allogeneic stem cell transplant recipient.

21 January 2018

1 reference

Adoptive T-cell therapy of a lung transplanted patient with severe CMV disease and resistance to antiviral therapy

21 January 2018

1 reference

Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease

21 January 2018

1 reference

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease.

21 January 2018

1 reference

Effective treatment of metastatic forms of Epstein-Barr virus-associated nasopharyngeal carcinoma with a novel adenovirus-based adoptive immunotherapy

21 January 2018

1 reference

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers

21 January 2018

1 reference

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

21 January 2018

1 reference

Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects

21 January 2018

1 reference

21 January 2018

1 reference

Human cytomegalovirus infection induces a rapid and sustained change in the expression of NK cell receptors on CD8+ T cells

21 January 2018

1 reference

Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR.

21 January 2018

1 reference

Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung.

21 January 2018

1 reference

Different patterns of peripheral migration by memory CD4+ and CD8+ T cells.

21 January 2018

1 reference

Phenotypic and functional heterogeneity of human memory B cells

21 January 2018

1 reference

Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation

21 January 2018

1 reference

Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles.

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus immune modulation: an overview

21 January 2018

1 reference

A viral inhibitor of peptide transporters for antigen presentation

21 January 2018

1 reference

A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates

21 January 2018

1 reference

Downregulation of class I major histocompatibility complex surface expression by varicella-zoster virus involves open reading frame 66 protein kinase-dependent and -independent mechanisms.

21 January 2018

1 reference

Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasion

21 January 2018

1 reference

The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation

21 January 2018

1 reference

A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition

21 January 2018

1 reference

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing

21 January 2018

1 reference

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity

21 January 2018

1 reference

The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18.

21 January 2018

1 reference

Identification of a TAP-independent, immunoproteasome-dependent CD8+ T-cell epitope in Epstein-Barr virus latent membrane protein 2.

21 January 2018

1 reference

Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection

21 January 2018

1 reference

An HLA-A2-restricted T-cell epitope mapped to the BNLF2a immune evasion protein of Epstein-Barr virus that inhibits TAP.

21 January 2018

1 reference

Frequent recognition of BCRF1, a late lytic cycle protein of Epstein-Barr virus, in the HLA-B*2705 context: evidence for a TAP-independent processing

21 January 2018

1 reference

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cells

21 January 2018

1 reference

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

21 January 2018

1 reference